Search

Search Constraints

You searched for: Subject 616.0798

Search Results

963. VHH antibody targeting the chemokine receptor CX3CR1 inhibits progression of atherosclerosis. Issue 1 (1st January 2020)

964. VHH antibody targeting the chemokine receptor CX3CR1 inhibits progression of atherosclerosis. Issue 1 (1st January 2020)

966. Waiving in vivo studies for monoclonal antibody biosimilar development: National and global challenges. Issue 3 (2nd April 2016)

967. When monoclonal antibodies are not monospecific: Hybridomas frequently express additional functional variable regions. Issue 4 (19th May 2018)

968. XGFR*, a novel affinity-matured bispecific antibody targeting IGF-1R and EGFR with combined signaling inhibition and enhanced immune activation for the treatment of pancreatic cancer. Issue 4 (18th May 2016)